Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
Clinical trial NCT05552469 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05552469
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-08
- Primary completion
- 2027-01-13
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.